Stroke prognosis in diabetes mellitus: new insights but questions remain

References

• Mankovsky BN, Metzger BE, Molitch ME, Biller J. Cerebrovascular disorders in patients with diabetes mellitus. J. Diabetes Complicat.10, 228–242 (1996).
   PubMed Web of Science ®Google Scholar
• Lukovits TG, Mazzone T, Gorelick PB. Diabetes mellitus and cerebrovascular disease. Neuroepidemiology18, 1–14 (1999).
   Google Scholar
• Alex M, Baron EK, Goldenberg S, Blumenthal HT. An autopsy study of cerebrovascular accident in diabetes mellitus. Circulation25, 663–673 (1962).
   Google Scholar
• Fisher CM. Lacunes: small, deep cerebral infarcts. Neurology15, 774–784 (1965).
   PubMed Web of Science ®Google Scholar
• Norrving B, Staaf G. Pure motor stroke from presumed lacunar infarct. Incidence, risk factors and initial course. Cerebrovasc. Dis.1, 203–209 (1991).
   Google Scholar
• Arboix A, Martí-Vilalta JL. Lacunar stroke. Expert Rev. Neurother.9(2), 179–196 (2009).
   PubMed Web of Science ®Google Scholar
• Mast H, Thompson JLP, Lee SH, Mohr JP, Sacco RL. Hypertension and diabetes mellitus as determinants of multiple lacunar infarcts. Stroke26, 30–33 (1995).
   PubMedGoogle Scholar
• Benavente O, White CL, Roldan AM. Small vessel strokes. Curr. Cardiol. Rep.7, 23–28 (2005).
   PubMedGoogle Scholar
• Arboix A, Font A, Garro C, Comes E, Massons J. Recurrent lacunar infarction following a previous lacunar stroke: a clinical study of 122 patients. J. Neurol. Neurosurg. Psychiatr.78, 1392–1394 (2007).
   PubMed Web of Science ®Google Scholar
• Jørgensen HS, Nakayama H, Raaschou HO, Olsen TS. Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke25, 1977–1984 (1994).
   PubMed Web of Science ®Google Scholar
• Lithner F, Asplund K, Eriksson S, Hägg E, Strand T, Wester PO. Clinical characteristics in diabetic stroke patients. Particularités cliniques chez les diabétiques présentant un accident vasculaire cérébral. Diabetes Metab.14, 15–19 (1988).
   Google Scholar
• Arboix A, Rivas A, Garcia-Eroles L, De Marcos L, Massons J, Oliveres M. Cerebral infarction in diabetes: clinical pattern, stroke subtypes, and predictors of in-hospital mortality. BMC Neurol.5(1), 9 (2005).
   Google Scholar
• Arboix A, Milian M, Oliveres M, Garcia-Eroles L, Massons J. Impact of female gender on prognosis in Type 2 diabetic patients with ischemic stroke. Eur. Neurol.56, 6–12 (2006).
   Google Scholar
• Megherbi SE, Milan C, Minier D et al. Association between diabetes and stroke subtype on survival and functional outcome 3 months after stroke. Data from the European BIOMED Stroke Project. Stroke34, 688–694 (2003).
   PubMed Web of Science ®Google Scholar
• Song E-C, Chu K, Jeong S-W et al. Hyperglycemia exacerbates brain edema and perihematomal cell death after intracerebral hemorrhage. Stroke34, 2215–2220 (2003).
   PubMed Web of Science ®Google Scholar
• Arboix A, Oliveres M, Massons J, Targa C, García-Eroles L. Diabetes is an independent risk factor for in-hospital mortality from acute spontaneous intracerebral hemorrhage. Diabetes Care23, 1527–1532 (2000).
   Google Scholar
• Lindsberg PJ, Roine RO. Hyperglycemia in acute stroke. Stroke35, 363–364 (2004).
   PubMed Web of Science ®Google Scholar
• Fuentes B, Castillo J, San José B et al. The prognostic value of capillary glucose levels in acute stroke. The GLycemia in Acute Stroke (GLIAS) Study. Stroke40, 562–568 (2009).
   PubMed Web of Science ®Google Scholar
• Parsons MW, Barber PA, Desmond PM et al. Acute hyperglycemia adversely affects stroke outcome: a magnetic resonance imaging and spectroscopy study. Ann. Neurol.52, 20–28 (2002).
   PubMed Web of Science ®Google Scholar
• The European Stroke Organisation (ESO) Executive Committee, ESO Writing Committee. Guidelines for management of ischemic stroke and transient ischemic attack 2008. Cerebrovasc. Dis.25, 457–507 (2008).
   PubMed Web of Science ®Google Scholar
• Wilcox R, Bousser MG, Betteridge DJ et al. Effects of pioglitazone in patients with Type 2 diabetes with or without previous stroke: results from Proactive (PRO-spective Pioglitazone Clinical Trial in Macrovascular Events 04). Stroke38, 865–873 (2007).
   PubMed Web of Science ®Google Scholar
• Rubiera M, Ribó M, Delgado-Mederos R et al. Tandem internal carotid artery/middle cerebral artery occlusion. An independent predictor of poor outcome after systemic thrombolysis. Stroke37, 2301–2305 (2006).
   PubMed Web of Science ®Google Scholar
• Launer LJ. Diabetes: vascular or neurodegenerative. An epidemiological perspective. Stroke40(Suppl. 1), S53–S55 (2009).
   Google Scholar
• Pasquier F, Boulogne A, Leys D, Fontaine P. Diabetes mellitus and dementia. Diabetes Metab.32, 403–414 (2006).
   PubMed Web of Science ®Google Scholar
• Young SE, Mainous AG, Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care29, 2688–2693 (2006).
   PubMed Web of Science ®Google Scholar
• Biessels GJ, Stackcenborg S, Brunner E. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol.5, 64–74 (2006).
   PubMed Web of Science ®Google Scholar
• Qiu WQ, Folstein MF. Insulin, insulin-degrading enzyme an amyloid b peptide in Alzheimer’s disease: review and hypothesis. Neurobiol. Aging27, 190–198 (2006).
   PubMed Web of Science ®Google Scholar
• Yaffe K, Kanaya A, Lindquist K et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA292, 2237–2242 (2004).
   PubMed Web of Science ®Google Scholar
• Kumari M, Brunner E, Fuhrer R. Minireview: mechanisms by which the metabolic syndrome and diabetes impair memory. J. Gerontol. A Biol. Sci. Med. Sci.5, 228–232 (2000).
   Google Scholar
• Gustafson D. Adiposity indices and dementia. Lancet Neurol.5, 713–720 (2006).
   PubMed Web of Science ®Google Scholar
• Benoit SC, Clegg DJ, Seeley RJ et al. Insulin and leptin as adiposity signals. Recent Prog. Horm. Res.59, 267–285 (2004).
   PubMedGoogle Scholar
• Kwon HM, Kim BJ, Lee SH et al. Metabolic syndrome as an independent risk factor of silent brain infarction in healthy people. Stroke37, 466–470 (2006).
   PubMed Web of Science ®Google Scholar
• Van der Flier WM, Barkhof F, Scheltens P. Shifting paradigms in dementia: toward stratification of diagnosis and treatment using MRI. Ann. NY Acad. Sci.1097, 215–224 (2007).
   PubMed Web of Science ®Google Scholar
• Henry-Feugeas MC. Alzheimer’s disease in late-life dementia: A minor toxic consequence of devastating cerebrovascular dysfunction. Med. Hypotheses70, 866–875 (2008).
   Google Scholar
• De la Torre JC. Alzheimer’s disease is a vasocognopathy: a new term to describe its nature. Neurol. Res.26, 517–524 (2004).
   PubMed Web of Science ®Google Scholar
• Wardlaw JM, Sandercock PAG, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke34, 806–812 (2003).
   PubMed Web of Science ®Google Scholar
• Lindley RI, Wang JJ, Wong M-Ch et al. Retinal microvascular changes in acute lacunar stroke. Lancet Neurol.8, 628–634 (2009).
   Google Scholar
• Arboix A. Retinal microvasculature in acute lacunar stroke. Lancet Neurol.8, 596–598 (2009).
   Google Scholar
• Zhu CZ, Auer RN. Optimal blood glucose levels while using insulin to minimize the size of infarction in focal cerebral ischemia. J. Neurosurg.101, 664–668 (2004).
   Google Scholar
• Simard JM, Kent TA, Chen M, Tarasov KV, Gerzanich V. Brain oedema in focal ischemia: molecular pathophysiology and theoretical implications. Lancet Neurol.6, 258–268 (2007).
   PubMed Web of Science ®Google Scholar
• Simard JM, Yurovsky V, Tsymbalyuk N, Melnichenko L, Ivanova S, Gerzanich V. Protective effect of delayed treatment with low-dose glibenclamide in three models of ischemic stroke. Stroke40, 604–609 (2009).
   PubMed Web of Science ®Google Scholar
• Simard JM, Chen M, Tarasov KV et al. Newly expressed SURI-regulated NC(Ca-ATP) channel mediates cerebral edema after ischemic stroke. Nat. Med.12, 433–440 (2006).
   PubMed Web of Science ®Google Scholar
• Stumvoll M, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet365, 1333–1346 (2005).
   PubMed Web of Science ®Google Scholar
• Arboix A. Potential impact of sulfonylureas in the outcome of Type 2 diabetic patients with ischemic stroke. Stroke38, 2413–2414 (2007).
   Google Scholar
• Kinte H, Schmidt S, Eliasziw M et al. Sulfonylureas improve outcome in patients with Type 2 diabetes and acute ischemic stroke. Stroke38, 2526–2530 (2007).
   Google Scholar
• Shook SJ, Gupta R, Vora NA, Tievsky AL, Katzan I, Krieger DW. Statin use is independently associated with smaller infarct volume in nonlacunar MCA territory stroke. J. Neuroimaging16, 341–346 (2006).
   PubMed Web of Science ®Google Scholar
• Streifler JY. Editorial comment: statins, stroke outcome, and stroke prevention: when should we start treatment? Stroke35, 1121 (2004).
   Google Scholar
• Arboix A, Cabeza N, Garcia-Eroles L et al. Relevance of transient ischemic attack to early neurological recovery after nonlacunar ischemic stroke. Cerebrovasc. Dis.18, 304–311 (2004).
   PubMed Web of Science ®Google Scholar
• Glazier SS, O’Rourke DM, Graham DI, Welsh FA. Induction of ischemic tolerance following brief local focal ischemic in rat brain. J. Cereb. Blood Flow Metab.14, 545–553 (1994).
   PubMed Web of Science ®Google Scholar
• Ovbiagele B, Saver JL. Intensive statin therapy after stroke or transient ischemic attack. A sparcling success? Stroke38, 1110–1112 (2007).
   Google Scholar